Trial intelligence / Profile preview

Topical clobetasol mouthwash for symptomatic oral lichen planus

2018-004222-28Phase 4Active

Sponsor
Malmö University
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of clobetasol in oral lichen planus (OLP), sponsored by Malmö University. Primary endpoint: Change in lesion activity score. Started Jan 2020; status: active.

02

Drugs

clobetasol
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on 2018-004222-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-004222-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call